Skip to main content
Clinical Trials/NCT04917640
NCT04917640WithdrawnNot Applicable

Accelerated Partial Breast Irradiation (PBI) With Stereotactic Body Radiation Therapy (SBRT) or Intensity Modulated Radiation Therapy (IMRT)

GenesisCare USA1 site in 1 countryStarted: June 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Sponsor
Locations
1
Primary Endpoint
Number of participants with treatment and toxicity-related adverse events as assessed by CTCAE v4.0".

Study Overview

Brief Summary

This is a registry study that will be used to evaluate external beam radiation therapy methods for the accelerated treatment of breast cancer. Patients are being asked to take part in this registry because they have breast cancer and desire treatment with accelerated partial breast irradiation to be delivered by external beam methods.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
50 Years to 100 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Greater than or equal to 50 years old Low to intermediate DCIS Tumor size < or = to 2cm

Exclusion Criteria

  • BRCA positive Lobular histology Angiolymphatic invasion

Outcomes

Primary Outcomes

Number of participants with treatment and toxicity-related adverse events as assessed by CTCAE v4.0".

Time Frame: Through study completion, an average of 12 months

Toxicity will be assessed using the CTCAEv4.0 and recorded.

Secondary Outcomes

  • Number of participants with ipsilateral breast recurrence(Through study completion, an average of 12 months)

Investigators

Sponsor
GenesisCare USA
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials